These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10065634)

  • 1. Immune effector mechanism in parasitic infections.
    Liew FY; Xu D; Chan WL
    Immunol Lett; 1999 Jan; 65(1-2):101-4. PubMed ID: 10065634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-leishmania effector functions of CD4+ Th1 cells and early events instructing Th2 cell development and susceptibility to Leishmania major in BALB/c mice.
    Louis JA; Conceiçao-Silva F; Himmelrich H; Tacchini-Cottier F; Launois P
    Adv Exp Med Biol; 1998; 452():53-60. PubMed ID: 9889959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-9 is a susceptibility factor in Leishmania major infection by promoting detrimental Th2/type 2 responses.
    Arendse B; Van Snick J; Brombacher F
    J Immunol; 2005 Feb; 174(4):2205-11. PubMed ID: 15699153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
    Bretscher PA; Ogunremi O; Menon JN
    Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA.
    von Stebut E; Belkaid Y; Nguyen B; Wilson M; Sacks DL; Udey MC
    J Invest Dermatol; 2002 Sep; 119(3):621-8. PubMed ID: 12230504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental Leishmania major infection in mice: role of IL-10.
    Chatelain R; Mauze S; Coffman RL
    Parasite Immunol; 1999 Apr; 21(4):211-8. PubMed ID: 10320618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling through the T1/ST2 molecule is not necessary for Th2 differentiation but is important for the regulation of type 1 responses in nonhealing Leishmania major infection.
    Kropf P; Herath S; Klemenz R; Müller I
    Infect Immun; 2003 Apr; 71(4):1961-71. PubMed ID: 12654814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
    Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
    PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4.
    Mocci S; Coffman RL
    J Immunol; 1995 Apr; 154(8):3779-87. PubMed ID: 7706719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KM(+), a lectin from Artocarpus integrifolia, induces IL-12 p40 production by macrophages and switches from type 2 to type 1 cell-mediated immunity against Leishmania major antigens, resulting in BALB/c mice resistance to infection.
    Panunto-Castelo A; Souza MA; Roque-Barreira MC; Silva JS
    Glycobiology; 2001 Dec; 11(12):1035-42. PubMed ID: 11805076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility to Leishmania major infection in interleukin-4-deficient mice.
    Noben-Trauth N; Kropf P; Müller I
    Science; 1996 Feb; 271(5251):987-90. PubMed ID: 8584936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 deficiency influences cytokine expression in susceptible BALB mice infected with Leishmania major but does not alter the outcome of disease.
    Titus RG; DeKrey GK; Morris RV; Soares MB
    Infect Immun; 2001 Aug; 69(8):5189-92. PubMed ID: 11447205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the production of soluble IL-4 receptors in murine cutaneous leishmaniasis. The roles of IL-12 and IL-4.
    Fernandez-Botran R; Chilton PM; Hondowicz BD; Vetvickova J; Yan J; Jones W; Scott P
    J Leukoc Biol; 1999 Sep; 66(3):481-8. PubMed ID: 10496319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
    Krishnan L; Guilbert LJ; Russell AS; Wegmann TG; Mosmann TR; Belosevic M
    J Immunol; 1996 Jan; 156(2):644-52. PubMed ID: 8543816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parasite dose determines the Th1/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite.
    Menon JN; Bretscher PA
    Eur J Immunol; 1998 Dec; 28(12):4020-8. PubMed ID: 9862338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of prolactin-inducible protein leads to impaired Th1 immune response and susceptibility to Leishmania major in mice.
    Li J; Liu D; Mou Z; Ihedioha OC; Blanchard A; Jia P; Myal Y; Uzonna JE
    Eur J Immunol; 2015 Apr; 45(4):1082-91. PubMed ID: 25594453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of polarized T helper 1 and T helper 2 cell populations in murine leishmaniasis.
    Coffman RL; Correa-Oliviera R; Mocci S
    Ciba Found Symp; 1995; 195():20-5; discussion 25-33. PubMed ID: 8724828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Th2 cytokines and the stable Th2 marker ST2L in the absence of IL-4 during Leishmania major infection.
    Kropf P; Schopf LR; Chung CL; Xu D; Liew FY; Sypek JP; Müller I
    Eur J Immunol; 1999 Nov; 29(11):3621-8. PubMed ID: 10556817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility to Leishmania major in IL-4 transgenic mice is not correlated with the lack of a Th1 immune response.
    Erb KJ; Blank C; Moll H
    Immunol Cell Biol; 1996 Jun; 74(3):239-44. PubMed ID: 8799723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of alternative macrophage activation delays cutaneous leishmaniasis in nonhealing BALB/c mice.
    Hölscher C; Arendse B; Schwegmann A; Myburgh E; Brombacher F
    J Immunol; 2006 Jan; 176(2):1115-21. PubMed ID: 16394000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.